shorts are going to have a tough day tomorrow
absolutely expected....it could come back a few percentages more going into next month's earnings. i would be buying the winners...those that have been reporting growth the last few qtrs. its a welcome pull back.
wow...i started this thread soon after the press release and people didn't bother to run until a couple of hours later...this stock is going back to the teens. not bashing here...delay after delay for the nda...this whole thing is over for acadia. i traded it when it was 7 bucks into the teens and didn't like it. and never look back.
delay in nda for the drug means there is a problem...not reliable...
so the ceo takes the blame and forced out the door. the drug is now in question. wake up.
the stock going to double in a few years. i have been in this stock for a while. following what is going on and know where it is going. i just keep adding from time to time.
as af's article points out, it was a completely wrong move by abbv management, the ceo in particular...discount yes, but not like that...either way, they would not have been able to compete with gild...but giving up 40 percent plus vs., say 30 percent or whatever...esrx doesn't have alternatives...either gild or abbv...
i said it just a few weeks ago...abbv didn't have to do it...time to fire the ceo.
lots of upside remaining in this stock. ripe to start buying around 90 here
why bother to respond to that dumb post anyways? icpt's drug will be on the market sooner than expected with the fda designation. so just stop wasting time on the nonsense mb trash you read. pay attention to what the company has to report and update instead.